SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder recommended in Scotland – but not England

Posted on 3 September, 2020 - Major Depressive Disorder

The Janssen Pharmaceutical Companies of Johnson & Johnson are delighted that the Scottish Medicines Consortium (SMC) accepted SPRAVATO®▼ (esketamine) nasal spray (7th September 2020) for use within NHS Scotland in combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant Major Depressive Disorder (TRD), who have not responded…

UKABIF Film Award Winner

Posted on 30 July, 2020 - Acquired Brain Injury

Sacha Paynter from Bristol has won the United Kingdom Acquired Brain Injury Forum (UKABIF) Film Award for her film ‘Talking Benefits’, sponsored by Cygnet Health Care.  Sacha’s short film looks at the importance of neurorehabilitation for individuals who have had an Acquired Brain Injury (ABI).  The film is based on Sacha’s personal family experiences of…

Online auction for Newly Injured Scheme

Posted on 23 July, 2020 - Charity, Rehabilitation

Neurokinex, a specialist paralysis rehabilitation charity with sites at Gatwick, Hemel and Bristol, is running an online auction for two weeks from noon on Friday July 17th until noon on Friday July 31st to raise funds to safeguard the future of its Newly Injured Scheme. The auction includes a wide choice of lots including sports…

ACT Myself -supporting mental health in MS

Posted on 23 June, 2020 - Industry News

Biogen launches ACT Myself – a free digital self-help tool to support the mental health of people living with multiple sclerosis (MS) as NHS highlights rise in anxiety among patients Biogen has launched a free, new, digital self-help tool to help people living with multiple sclerosis (MS) navigate the emotional challenges of life with the…